Cytomegalovirus Disease Treatments Market - Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: CFB887CA1151EN
Market Monitor Global

Abstracts

Cytomegalovirus disease (CMV) is a viral infection that can affect one part of the body, such as the eyes, or it can spread throughout the body.

This report contains market size and forecasts of Cytomegalovirus Disease Treatments in Global, including the following market information:

Global Cytomegalovirus Disease Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cytomegalovirus Disease Treatments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Ganciclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cytomegalovirus Disease Treatments include Merck, Chimerix, Abbott, Bio-Rad, Roche and Gilead Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cytomegalovirus Disease Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cytomegalovirus Disease Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cytomegalovirus Disease Treatments Market Segment Percentages, by Type, 2021 (%)

• Ganciclovir
• Valganciclovir
• Foscarnet
• Cidofovir
• Others

Global Cytomegalovirus Disease Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cytomegalovirus Disease Treatments Market Segment Percentages, by Application, 2021 (%)

• Stem Cell Transplantation
• Organ Transplantation
• Congenital CMV Infection
• Others

Global Cytomegalovirus Disease Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cytomegalovirus Disease Treatments Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cytomegalovirus Disease Treatments revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cytomegalovirus Disease Treatments revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Chimerix
• Abbott
• Bio-Rad
• Roche
• Gilead Sciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cytomegalovirus Disease Treatments Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cytomegalovirus Disease Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CYTOMEGALOVIRUS DISEASE TREATMENTS OVERALL MARKET SIZE

2.1 Global Cytomegalovirus Disease Treatments Market Size: 2021 VS 2028
2.2 Global Cytomegalovirus Disease Treatments Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cytomegalovirus Disease Treatments Players in Global Market
3.2 Top Global Cytomegalovirus Disease Treatments Companies Ranked by Revenue
3.3 Global Cytomegalovirus Disease Treatments Revenue by Companies
3.4 Top 3 and Top 5 Cytomegalovirus Disease Treatments Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cytomegalovirus Disease Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cytomegalovirus Disease Treatments Players in Global Market
  3.6.1 List of Global Tier 1 Cytomegalovirus Disease Treatments Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cytomegalovirus Disease Treatments Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cytomegalovirus Disease Treatments Market Size Markets, 2021 & 2028
  4.1.2 Ganciclovir
  4.1.3 Valganciclovir
  4.1.4 Foscarnet
  4.1.5 Cidofovir
  4.1.6 Others
4.2 By Type - Global Cytomegalovirus Disease Treatments Revenue & Forecasts
  4.2.1 By Type - Global Cytomegalovirus Disease Treatments Revenue, 2017-2022
  4.2.2 By Type - Global Cytomegalovirus Disease Treatments Revenue, 2023-2028
  4.2.3 By Type - Global Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cytomegalovirus Disease Treatments Market Size, 2021 & 2028
  5.1.2 Stem Cell Transplantation
  5.1.3 Organ Transplantation
  5.1.4 Congenital CMV Infection
  5.1.5 Others
5.2 By Application - Global Cytomegalovirus Disease Treatments Revenue & Forecasts
  5.2.1 By Application - Global Cytomegalovirus Disease Treatments Revenue, 2017-2022
  5.2.2 By Application - Global Cytomegalovirus Disease Treatments Revenue, 2023-2028
  5.2.3 By Application - Global Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cytomegalovirus Disease Treatments Market Size, 2021 & 2028
6.2 By Region - Global Cytomegalovirus Disease Treatments Revenue & Forecasts
  6.2.1 By Region - Global Cytomegalovirus Disease Treatments Revenue, 2017-2022
  6.2.2 By Region - Global Cytomegalovirus Disease Treatments Revenue, 2023-2028
  6.2.3 By Region - Global Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cytomegalovirus Disease Treatments Revenue, 2017-2028
  6.3.2 US Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.3.3 Canada Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.3.4 Mexico Cytomegalovirus Disease Treatments Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cytomegalovirus Disease Treatments Revenue, 2017-2028
  6.4.2 Germany Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.4.3 France Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.4.4 U.K. Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.4.5 Italy Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.4.6 Russia Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.4.7 Nordic Countries Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.4.8 Benelux Cytomegalovirus Disease Treatments Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cytomegalovirus Disease Treatments Revenue, 2017-2028
  6.5.2 China Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.5.3 Japan Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.5.4 South Korea Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.5.5 Southeast Asia Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.5.6 India Cytomegalovirus Disease Treatments Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cytomegalovirus Disease Treatments Revenue, 2017-2028
  6.6.2 Brazil Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.6.3 Argentina Cytomegalovirus Disease Treatments Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cytomegalovirus Disease Treatments Revenue, 2017-2028
  6.7.2 Turkey Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.7.3 Israel Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.7.4 Saudi Arabia Cytomegalovirus Disease Treatments Market Size, 2017-2028
  6.7.5 UAE Cytomegalovirus Disease Treatments Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Cytomegalovirus Disease Treatments Major Product Offerings
  7.1.4 Merck Cytomegalovirus Disease Treatments Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Chimerix
  7.2.1 Chimerix Corporate Summary
  7.2.2 Chimerix Business Overview
  7.2.3 Chimerix Cytomegalovirus Disease Treatments Major Product Offerings
  7.2.4 Chimerix Cytomegalovirus Disease Treatments Revenue in Global Market (2017-2022)
  7.2.5 Chimerix Key News
7.3 Abbott
  7.3.1 Abbott Corporate Summary
  7.3.2 Abbott Business Overview
  7.3.3 Abbott Cytomegalovirus Disease Treatments Major Product Offerings
  7.3.4 Abbott Cytomegalovirus Disease Treatments Revenue in Global Market (2017-2022)
  7.3.5 Abbott Key News
7.4 Bio-Rad
  7.4.1 Bio-Rad Corporate Summary
  7.4.2 Bio-Rad Business Overview
  7.4.3 Bio-Rad Cytomegalovirus Disease Treatments Major Product Offerings
  7.4.4 Bio-Rad Cytomegalovirus Disease Treatments Revenue in Global Market (2017-2022)
  7.4.5 Bio-Rad Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Cytomegalovirus Disease Treatments Major Product Offerings
  7.5.4 Roche Cytomegalovirus Disease Treatments Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 Gilead Sciences
  7.6.1 Gilead Sciences Corporate Summary
  7.6.2 Gilead Sciences Business Overview
  7.6.3 Gilead Sciences Cytomegalovirus Disease Treatments Major Product Offerings
  7.6.4 Gilead Sciences Cytomegalovirus Disease Treatments Revenue in Global Market (2017-2022)
  7.6.5 Gilead Sciences Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cytomegalovirus Disease Treatments Market Opportunities & Trends in Global Market
Table 2. Cytomegalovirus Disease Treatments Market Drivers in Global Market
Table 3. Cytomegalovirus Disease Treatments Market Restraints in Global Market
Table 4. Key Players of Cytomegalovirus Disease Treatments in Global Market
Table 5. Top Cytomegalovirus Disease Treatments Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cytomegalovirus Disease Treatments Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cytomegalovirus Disease Treatments Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cytomegalovirus Disease Treatments Product Type
Table 9. List of Global Tier 1 Cytomegalovirus Disease Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cytomegalovirus Disease Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cytomegalovirus Disease Treatments Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cytomegalovirus Disease Treatments Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cytomegalovirus Disease Treatments Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cytomegalovirus Disease Treatments Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cytomegalovirus Disease Treatments Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cytomegalovirus Disease Treatments Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Cytomegalovirus Disease Treatments Product Offerings
Table 32. Merck Cytomegalovirus Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 33. Chimerix Corporate Summary
Table 34. Chimerix Cytomegalovirus Disease Treatments Product Offerings
Table 35. Chimerix Cytomegalovirus Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Cytomegalovirus Disease Treatments Product Offerings
Table 38. Abbott Cytomegalovirus Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 39. Bio-Rad Corporate Summary
Table 40. Bio-Rad Cytomegalovirus Disease Treatments Product Offerings
Table 41. Bio-Rad Cytomegalovirus Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Cytomegalovirus Disease Treatments Product Offerings
Table 44. Roche Cytomegalovirus Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 45. Gilead Sciences Corporate Summary
Table 46. Gilead Sciences Cytomegalovirus Disease Treatments Product Offerings
Table 47. Gilead Sciences Cytomegalovirus Disease Treatments Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cytomegalovirus Disease Treatments Segment by Type in 2021
Figure 2. Cytomegalovirus Disease Treatments Segment by Application in 2021
Figure 3. Global Cytomegalovirus Disease Treatments Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cytomegalovirus Disease Treatments Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cytomegalovirus Disease Treatments Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cytomegalovirus Disease Treatments Revenue in 2021
Figure 8. By Type - Global Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028
Figure 12. US Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028
Figure 16. Germany Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 17. France Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028
Figure 24. China Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 28. India Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028
Figure 30. Brazil Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cytomegalovirus Disease Treatments Revenue Market Share, 2017-2028
Figure 33. Turkey Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cytomegalovirus Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Cytomegalovirus Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Chimerix Cytomegalovirus Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Cytomegalovirus Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bio-Rad Cytomegalovirus Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Cytomegalovirus Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gilead Sciences Cytomegalovirus Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)